Agilent acquires Stratagene

Friday, 08 June, 2007

Agilent Technologies has announced the acquisition of the company Stratagene, effective as of today.

The takeover is hoped to assist the company in providing more complete workflow solutions in genomics, proteomics and metabolomics.

Stratagene will operate as a division of the company's Life Sciences Solutions unit.

The company has said current customers should expect no change in the way they work with Stratagene and should be able to continue using their existing contact channels.

L'Oréal-UNESCO For Women In Science Fellows announced for ANZ

This year's program honours four women who are reshaping what leadership in research looks...

Peter Beattie appointed Chair of Brandon BioCatalyst

Brandon BioCatalyst has announced new board appointments to continue the scaling of Australian...

Virologist receives GSK Award for AI-based disease detection

Professor Edward Holmes has received the 2025 GSK Award for Research Excellence for his use of...

Content from other channels on our network

SA launches strategy to "virtually eliminate HIV transmission" by 2030

High-end heritage: expanded St Vincent's Private Hospital, Fitzroy

Revised 2025 edition of Australian Asthma Handbook now available

AdPha marks World Patient Safety Day with Medication Safety article series

Tas doctors "strongly oppose" any taxpayer-funded home birth scheme

Not all mercury is toxic: bluefin tuna study reveals more

Packaging partnership to develop compostable lidding

Beef processor achieves AUS-MEAT approval for carcase grading

How will Australia's new climate targets impact manufacturing?

Award-winning design on Johnnie Walker Bottles uses digital inkjet technology

Victoria approves its largest grid battery system to date

Yokogawa technology to go to the Moon

Government announces $1.1bn for cleaner fuel production

ABB Robotics invests in vision AI company

Green Gravity and Wollongong City sign MOU for clean energy innovation